Press Release Aug 8, 2023

Jacobs Reports Fiscal Third Quarter 2023 Earnings

  • Save to favorites
    Share with your friends

Third Quarter Revenue up 9% Year-Over-Year; 10% in Constant Currency1

People and Places Solutions Operating Profit up 13% Year-Over-Year

Operating Profit up 1% Year-Over-Year; Adjusted Operating Profit up 10%1

 Reiterates 100% Cash Flow Conversion Target; Reiterates Fiscal 2023 Outlook Range

Advancing Plans for Separation of Critical Mission Solutions Business

DALLAS, Aug. 8, 2023 /PRNewswire/ -- Jacobs Solutions Inc. (NYSE: J) today announced its financial results for the fiscal third quarter ended June 30, 2023.

Q3 2023 Highlights:

  • Revenue of $4.2 billion up 9.4% y/y; adjusted net revenue1 increased 7.5% y/y and up 7.9% in constant currency1
  • Backlog1 of $28.9 billion, up 2.9% y/y; gross margin in backlog1 up 7.1% y/y
  • EPS of $1.29, down 15.1% y/y; adjusted EPS from continuing operations1 of $1.82, down 2.2% y/y. Year-ago period benefited from gain of $0.08 per share related to a cost method investment sold
  • Strong cash provided by operations of $321 million; continue to expect 100% fiscal year underlying cash conversion

Jacobs' CEO Bob Pragada commented, "We continue to successfully execute against our strategic plan while we chart our path forward as two independent companies. Backlog remains near record levels and we have continued to focus on delivering improved operational performance against our robust opportunity set, led by People and Places Solutions operating profit growth of 13% year-over-year. We remain dedicated to maximizing long-term shareholder value and continue to advance the separation of our Critical Mission Solutions business."

Jacobs' President and CFO Kevin Berryman added, "We delivered strong third quarter results with accelerating revenue growth while continuing to expand operating profit margins. Gross margin in backlog continued to improve in Q3, which provides visibility supporting our fiscal year 2023 outlook and beyond. We repurchased $125.0 million in shares in Q3 as our healthy financial position and strong cash conversion allowed us to re-invest in the business while returning capital to shareholders.

"As I hand over the CFO role to Claudia next week, as previously announced, I want to say that it has been an honor to help lead this company over the past 8.5 years. I remain confident in the company's bright future and look forward to supporting Bob in my new role as his special advisor."

Financial Outlook2

The company has reiterated its outlook for fiscal year 2023 adjusted EBITDA to a range of $1,420 million to $1,470 million and adjusted EPS of $7.25 to $7.45.

Update on Planned Separation of Critical Mission Solutions ("CMS") business

On May 9, Jacobs announced its intent to pursue a separation of the Critical Mission Solutions ("CMS") business. The company continues to make significant progress on the many activities associated with the separation. In addition, following the announcement, there has been positive interest from multiple outside parties. We are currently evaluating this interest consistent with our commitment to maximize shareholder value.

As previously communicated, the spin-off, which is subject to customary conditions, is expected to be completed in fiscal 2024. Jacobs is committed to maintaining an investment grade profile for Jacobs following the separation. The proposed capital structure, governance and other matters relating to CMS are still being determined and will be communicated at a later date.

1See "Non-GAAP Financial Measures and Operating Metrics" and the GAAP Reconciliation tables that follow for additional detail. 
2Reconciliation of full year fiscal 2023 adjusted EPS outlook and adjusted EBITDA outlook to the most directly comparable GAAP measure is not available without unreasonable efforts because the Company cannot predict with sufficient certainty all the components required to provide such reconciliation, including with respect to the costs and charges and timing of costs and charges relating to expenses, restructuring and integration costs to be incurred in fiscal 2023.

Third Quarter Review

 

Fiscal Q3 2023

Fiscal Q3 2022

Change

Revenue

$4.2 billion

$3.8 billion

$400 million

Adjusted Net Revenue (1)

$3.4 billion

$3.1 billion

$300 million

GAAP Net Earnings from Continuing Operations

$164 million

$196 million

($32 million)

GAAP Earnings Per Diluted Share (EPS) from Continuing Operations

$1.29

$1.52

($0.23)

Adjusted Net Earnings from Continuing Operations

$231 million

$240 million

($9 million)

Adjusted EPS from Continuing Operations

$1.82

$1.86

($0.04)
 

(1) Pass-through revenues for the prior periods presented include certain minor adjustments to properly reflect amounts that
had not been previously included and to conform with the fiscal 2023 amounts presented.

The Company's adjusted net earnings from continuing operations and adjusted EPS from continuing operations for the third quarter of fiscal 2023 and fiscal 2022 exclude certain adjustments that are further described in the section entitled "Non-GAAP Financial Measures" at the end of this release. For a reconciliation of Revenue to Adjusted Net Revenue, see "Segment Information", below.

The Company's U.S. GAAP effective tax rate for continuing operations is 23.9% for the fiscal third quarter 2023, and fiscal third quarter 2023 adjusted earnings per share from continuing operations reflects an estimated full year fiscal 2023 adjusted effective tax rate of 21.0%. The Company's U.S. GAAP effective tax rate for continuing operations is 21.9% for the fiscal third quarter 2022, and fiscal third quarter 2022 adjusted earnings per share from continuing operations reflected an estimated full year fiscal 2022 adjusted effective tax rate of 21.7%.

Jacobs is hosting a conference call at 10:00 A.M. ET on Tuesday August 8, 2023, which it is webcasting live at www.jacobs.com.

Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not directly relate to any historical or current fact. When used herein, words such as "expects," "anticipates," "believes," "seeks," "estimates," "plans," "intends," "future," "will," "would," "could," "can," "may," "target," "goal" and similar words are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding our expectations as to our future growth, prospects, financial outlook and business strategy, including our expectations for our fiscal year 2023 adjusted EBITDA and adjusted EPS (including our outlook assumptions), revenue growth, free cash flow, and fiscal 2023 cash conversion to adjusted net income, our plans to separate the CMS business through a spin-off that is intended to be tax-free to stockholders for U.S. federal income tax purposes, our plans to review potential alternatives for the separation, the description of the CMS business following the separation, the timing of completion for the separation, and the perceived benefits for both Jacobs and CMS to be derived from the separation. Although such statements are based on management's current estimates and expectations, and/or currently available competitive, financial, and economic data, forward-looking statements are inherently uncertain, and you should not place undue reliance on such statements as actual results may differ materially. We caution the reader that there are a variety of risks, uncertainties and other factors that could cause actual results to differ materially from what is contained, projected or implied by our forward-looking statements. Such factors include uncertainties as to the final structure and timing of the separation of the CMS business, including with respect to the scope of the businesses to be separated or retained by the Company, the possibility that closing conditions for a separation transaction may not be satisfied or waived, the impact of the separation on the Company's and CMS's businesses and a possible decrease in the trading price of their shares, if the separation is completed, the possibility that the separation may not qualify for the expected tax treatment, the risk that any consents or approvals required in connection with the separation may not be received, the risk that the separation may be more difficult, time-consuming or costly than expected, and the possibility that we may not retain key employees while the separation is pending or after it is completed, as well as factors related to our business, such as our ability to fully execute on our three-year corporate strategy, including our ability to invest in the tools needed to implement our strategy, competition from existing and future competitors in our target markets, our ability to achieve the cost-savings and synergies contemplated by our recent acquisitions within the expected time frames or to achieve them fully and to successfully integrate acquired businesses while retaining key personnel, the impact of any pandemic, and any resulting economic downturn on our results, prospects and opportunities, measures or restrictions imposed by governments and health officials in response to the pandemic, the timing of the award of projects, and funding and potential changes to the amounts provided for, under the Infrastructure Investment and Jobs Act, any changes in U.S. or foreign tax laws, statutes, rules, regulations or ordinances that may adversely impact our future financial positions or results of operations, financial market risks that may affect the Company, including by impacting the Company's access to capital, the cost of such capital and/or the Company's funding obligations under defined benefit pension and postretirement plans, as well as general economic conditions, including inflation and the actions taken by monetary authorities in response to inflation, changes in interest rates and foreign currency exchange rates, changes in capital markets, the current banking crisis, the impact of a possible recession or economic downturn on our results, prospects and opportunities, and geopolitical events and conflicts among others. The impact of such matters includes, but is not limited to, the possibility that we will not complete the spin-off or any separation transaction or that the transaction will occur on terms or conditions that are different or less favorable than expected; the possible reduction in demand for certain of our product solutions and services and the delay or abandonment of ongoing or anticipated projects due to the financial condition of our clients and suppliers or to governmental budget constraints or changes to governmental budgetary priorities; the inability of our clients to meet their payment obligations in a timely manner or at all; potential issues and risks related to a significant portion of our employees working remotely; illness, travel restrictions and other workforce disruptions that have and could continue to negatively affect our supply chain and our ability to timely and satisfactorily complete our clients' projects; difficulties associated with retaining and hiring additional employees; and the inability of governments in certain of the countries in which we operate to effectively mitigate the financial or other impacts of a pandemic on their economies and workforces and our operations therein. The foregoing factors and potential future developments are inherently uncertain, unpredictable and, in many cases, beyond our control. For a description of these and additional factors that may occur that could cause actual results to differ from our forward-looking statements see our Annual Report on Form 10-K for the year ended September 30, 2022, and in particular the discussions contained therein under Item 1 - Business; Item 1A - Risk Factors; Item 3 - Legal Proceedings; and Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations, and Part II, Item 1A - Risk Factors, in our most recently filed Quarterly Report on Form 10-Q, as well as the Company's other filings with the Securities and Exchange Commission. The Company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law.

About Jacobs 

At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With approximately $15 billion in annual revenue and a talent force of more than 60,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sectors. Visit jacobs.com and connect with Jacobs on LinkedIn, Twitter, Facebook and Instagram.

 

Financial Highlights:
 

Results of Operations (in thousands, except per-share data):
 
 

For the Three Months Ended

  

For the Nine Months Ended

Unaudited

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Revenues

$     4,186,702

  

$     3,827,093

  

$   12,063,702

  

$   11,041,777

Direct cost of contracts

(3,329,959)

  

(3,002,618)

  

(9,501,953)

  

(8,550,418)

Gross profit

856,743

  

824,475

  

2,561,749

  

2,491,359

Selling, general and administrative expenses

(587,002)

  

(558,713)

  

(1,764,341)

  

(1,882,049)

Operating Profit

269,741

  

265,762

  

797,408

  

609,310

Other Income (Expense):

              

Interest income

7,830

  

1,042

  

18,467

  

2,924

Interest expense

(43,787)

  

(26,129)

  

(124,477)

  

(67,551)

Miscellaneous (expense) income, net

(7,099)

  

31,440

  

(14,920)

  

51,802

Total other (expense) income, net

(43,056)

  

6,353

  

(120,930)

  

(12,825)

Earnings from Continuing Operations Before Taxes

226,685

  

272,115

  

676,478

  

596,485

Income Tax Expense from Continuing Operations

(54,166)

  

(59,491)

  

(123,329)

  

(121,545)

Net Earnings of the Group from Continuing
Operations

172,519

  

212,624

  

553,149

  

474,940

Net Earnings (Loss) of the Group from Discontinued
Operations

294

  

(343)

  

(489)

  

(576)

Net Earnings of the Group

172,813

  

212,281

  

552,660

  

474,364

Net Earnings Attributable to Noncontrolling Interests
from Continuing Operations

(8,204)

  

(8,773)

  

(23,038)

  

(28,286)

Net Earnings Attributable to Redeemable
Noncontrolling interests

(370)

  

(7,525)

  

(13,225)

  

(27,246)

Net Earnings Attributable to Jacobs from Continuing
Operations

163,945

  

196,326

  

516,886

  

419,408

Net Earnings Attributable to Jacobs

$        164,239

  

$       195,983

  

$        516,397

  

$       418,832

Net Earnings Per Share:

              

Basic Net Earnings from Continuing Operations
Per Share

$              1.29

  

$             1.53

  

$              4.08

  

$             3.25

Basic Net Loss from Discontinued Operations Per
Share

$                 —

  

$                —

  

$                 —

  

$                —

Basic Earnings Per Share

$              1.30

  

$             1.53

  

$              4.07

  

$             3.25
               

Diluted Net Earnings from Continuing Operations
Per Share

$              1.29

  

$             1.52

  

$              4.06

  

$             3.23

Diluted Net Loss from Discontinued Operations
Per Share

$                 —

  

$                —

  

$                 —

  

$                —

Diluted Earnings Per Share

$              1.29

  

$             1.52

  

$              4.06

  

$             3.23
               

 

Segment Information (in thousands):
 
 

Three Months Ended

  

Nine Months Ended

Unaudited

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Revenues from External Customers:

              

Critical Mission Solutions

$      1,190,845

  

$      1,109,034

  

$     3,457,076

  

$     3,220,193

People & Places Solutions

2,469,694

  

2,222,530

  

7,041,744

  

6,306,520

Pass Through Revenue (1)

(783,143)

  

(673,767)

  

(2,177,366)

  

(1,775,287)

People & Places Solutions Adjusted Net
Revenue (1)

$      1,686,551

  

$      1,548,763

  

$     4,864,378

  

$     4,531,233

Divergent Solutions

$         239,289

  

$         217,949

  

$        694,978

  

$        650,120

Pass Through Revenue

(20,916)

  

(5,975)

  

(52,019)

  

(20,596)

Divergent Solutions Adjusted Net Revenue

$         218,373

  

$         211,974

  

$        642,959

  

$        629,524

PA Consulting

$         286,874

  

$         277,580

  

$        869,904

  

$        864,944

Total Revenue

$      4,186,702

  

$      3,827,093

  

$   12,063,702

  

$   11,041,777

Adjusted Net Revenue (1)

$      3,382,643

  

$      3,147,351

  

$     9,834,317

  

$     9,245,894
 
 
 

Three Months Ended

  

Nine Months Ended
 

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Segment Operating Profit:

              

Critical Mission Solutions

$           99,141

  

$           88,328

  

$         275,304

  

$        274,184

People & Places Solutions

242,673

  

213,930

  

701,498

  

595,485

Divergent Solutions

20,794

  

12,093

  

57,623

  

52,256

PA Consulting

60,864

  

51,448

  

177,521

  

182,850

Total Segment Operating Profit

423,472

  

365,799

  

1,211,946

  

1,104,775

Other Corporate Expenses (2)

(118,486)

  

(89,887)

  

(319,796)

  

(284,479)

Restructuring, Transaction and Other Charges
(3)

(35,245)

  

(10,150)

  

(94,742)

  

(210,986)

Total U.S. GAAP Operating Profit

269,741

  

265,762

  

797,408

  

609,310

Total Other (Expense) Income, net (4)

(43,056)

  

6,353

  

(120,930)

  

(12,825)

Earnings Before Taxes from Continuing Operations

$         226,685

  

$         272,115

  

$         676,478

  

$        596,485
   

(1)

Pass-through revenues for P&PS for the prior periods presented include certain minor adjustments to properly reflect amounts that had not been previously included and conform with the fiscal 2023 amounts presented.

(2)

Other corporate expenses included intangibles amortization of $52.0 million and $51.6 million for the three months ended June 30, 2023 and July 1, 2022, respectively, and $152.2 million and $146.9 million, for the nine months ended June 30, 2023 and July 1, 2022, respectively. Additionally, the nine month period of fiscal 2023 included approximately $15.0 million in net favorable impacts from cost reductions compared to the prior year period, which was associated mainly with net favorable impacts during first quarter from changes in employee benefit programs of $41 million offset by approximately $26 million in higher spend in company technology platforms and other personnel and corporate cost increases.

(3)

The three and nine months ended June 30, 2023 included $17.2 million in restructuring and other charges relating to the Company's investment in PA Consulting (primarily employee separation costs) and $13.4 million relating to the separation activities (mainly professional services) around the CMS separation, and the nine months ended June 30, 2023 and July 1, 2022 included $38.1 million and $74.6 million, respectively in real estate impairment charges relating to the Company's transformation initiatives. Also included in the nine months ended July 1, 2022 is $91.3 million related to the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves.

(4)

The three and nine month periods ended July 1, 2022 included a $13.9 million gain related to a cost method investment sold during the period. The nine months ended July 1, 2022 included $3.5 million in income associated with final exit activities associated with our AWE ML investment and a gain of $7.1 million related to a lease termination. Additionally, the unfavorable change in Other Expense, net for the periods presented are attributable mainly to higher net interest expense year over year, primarily due to higher interest rates as well as the full 2023 period impacts of increased levels of debt outstanding due to fiscal 2022 incremental borrowings associated with the funding of the StreetLight and BlackLynx acquisitions and the payment of the Legacy CH2M Matter settlement.

 

Balance Sheet (in thousands):
 
 

June 30, 2023

  

September 30, 2022
 

Unaudited

    

ASSETS

      

Current Assets:

      

Cash and cash equivalents

$          1,092,127

  

$              1,140,479

Receivables and contract assets

3,558,724

  

3,405,381

Prepaid expenses and other

172,896

  

176,134

Total current assets

4,823,747

  

4,721,994

Property, Equipment and Improvements, net

378,410

  

346,676

Other Noncurrent Assets:

      

Goodwill

7,414,558

  

7,184,658

Intangibles, net

1,354,677

  

1,394,052

Deferred income tax assets

28,626

  

31,480

Operating lease right-of-use assets

437,419

  

476,913

Miscellaneous

499,262

  

504,646

Total other noncurrent assets

9,734,542

  

9,591,749
 

$        14,936,699

  

$            14,660,419

LIABILITIES AND STOCKHOLDERS' EQUITY

      

Current Liabilities:

      

Current maturities of long-term debt

$               55,743

  

$                   50,415

Accounts payable

1,091,179

  

966,792

Accrued liabilities

1,238,545

  

1,441,762

Operating lease liability

152,945

  

150,171

Contract liabilities

761,574

  

641,705

Total current liabilities

3,299,986

  

3,250,845

Long-term debt

3,145,529

  

3,357,256

Liabilities relating to defined benefit pension and retirement plans

288,474

  

271,332

Deferred income tax liabilities

289,036

  

269,077

Long-term operating lease liability

570,321

  

607,447

Other deferred liabilities

126,590

  

167,548

Commitments and Contingencies

      

Redeemable Noncontrolling interests

644,347

  

632,522

Stockholders' Equity:

      

Capital stock:

      

Preferred stock, $1 par value, authorized - 1,000,000 shares; issued and outstanding -
none

—

  

—

Common stock, $1 par value, authorized - 240,000,000 shares; issued and outstanding -
125,880,738 shares and 127,393,378 shares as of June 30, 2023 and September 30, 2022,
respectively

125,881

  

127,393

Additional paid-in capital

2,707,494

  

2,682,009

Retained earnings

4,460,729

  

4,225,784

Accumulated other comprehensive loss

(772,388)

  

(975,130)

Total Jacobs stockholders' equity

6,521,716

  

6,060,056

Noncontrolling interests

50,700

  

44,336

Total Group stockholders' equity

6,572,416

  

6,104,392
 

$        14,936,699

  

$            14,660,419

 

Statement of Cash Flow (in thousands):
 
 

For the Three Months Ended

  

For the Nine Months Ended

Unaudited

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Cash Flows from Operating Activities:

              

Net earnings attributable to the Group

$         172,813

  

$        212,281

  

$         552,660

  

$         474,364

Adjustments to reconcile net earnings to net cash flows (used for) provided
by operations:

              

Depreciation and amortization:

              

Property, equipment and improvements

21,184

  

25,301

  

76,870

  

77,921

Intangible assets

51,985

  

51,551

  

152,232

  

146,889

Gain on investment in equity securities

—

  

(13,862)

  

—

  

(13,862)

Stock based compensation

20,623

  

16,544

  

55,908

  

41,705

Equity in earnings of operating ventures, net of return on capital
distributions

(32)

  

942

  

(2,963)

  

14,222

(Gain) loss on disposals of assets, net

(238)

  

(5,183)

  

590

  

(4,762)

Impairment of long-lived assets and equity method investment

914

  

—

  

38,131

  

74,585

Deferred (benefit) income taxes

(15,841)

  

46,104

  

4,944

  

62,144

Changes in assets and liabilities, excluding the effects of businesses acquired:

              

Receivables and contract assets, net of contract liabilities

(41,038)

  

(80,726)

  

22,191

  

(114,607)

Prepaid expenses and other current assets

2,696

  

13,047

  

(7,244)

  

28,963

Miscellaneous other assets

26,746

  

52,037

  

70,218

  

119,238

Accounts payable

124,251

  

35,974

  

109,142

  

54,422

Accrued liabilities

(56,430)

  

(547,886)

  

(285,287)

  

(667,868)

Other deferred liabilities

9,476

  

(41,254)

  

(44,420)

  

(74,559)

      Other, net

3,952

  

(13,957)

  

12,428

  

(21,626)

          Net cash provided by (used for) operating activities

321,061

  

(249,087)

  

755,400

  

197,169

Cash Flows from Investing Activities:

              

Additions to property and equipment

(30,851)

  

(31,830)

  

(98,240)

  

(80,053)

Disposals of property and equipment and other assets

1,522

  

8,222

  

1,537

  

9,286

Capital contributions to equity investees, net of return of capital
distributions

(420)

  

1,674

  

7,964

  

2,756

Acquisitions of businesses, net of cash acquired

—

  

(24,335)

  

(17,685)

  

(437,083)

Disposal of investment in equity securities

—

  

13,862

  

—

  

13,862

          Net cash used for investing activities

(29,749)

  

(32,407)

  

(106,424)

  

(491,232)

Cash Flows from Financing Activities:

              

Net (payments of) proceeds from borrowings

(284,712)

  

412,038

  

(338,555)

  

799,151

Debt issuance costs

(508)

  

—

  

(11,896)

  

—

Proceeds from issuances of common stock

12,677

  

12,800

  

38,051

  

40,987

Common stock repurchases

(125,047)

  

(200,709)

  

(265,569)

  

(250,709)

Taxes paid on vested restricted stock

(551)

  

(176)

  

(23,760)

  

(28,574)

Cash dividends to shareholders

(32,884)

  

(29,341)

  

(95,672)

  

(86,588)

Net dividends associated with noncontrolling interests

(6,004)

  

(6,687)

  

(17,287)

  

(16,103)

Repurchase of redeemable noncontrolling interests

(32,072)

  

(10,979)

  

(90,425)

  

(46,074)

Proceeds from issuances of redeemable noncontrolling interests

34,771

  

49,738

  

34,771

  

49,738

            Net cash (used for) provided by financing activities

(434,330)

  

226,684

  

(770,342)

  

461,828

Effect of Exchange Rate Changes

11,548

  

(67,127)

  

61,309

  

(79,919)

Net (Decrease) Increase in Cash and Cash Equivalents and Restricted Cash

(131,470)

  

(121,937)

  

(60,057)

  

87,846

Cash and Cash Equivalents, including Restricted Cash, at the Beginning of the
Period

1,225,620

  

1,236,358

  

1,154,207

  

1,026,575

Cash and Cash Equivalents, including Restricted Cash, at the End of the Period

$      1,094,150

  

$     1,114,421

  

$      1,094,150

  

$      1,114,421

 

Backlog (in millions):
 
 

June 30, 2023

  

July 1, 2022

Critical Mission Solutions

$               8,097

  

$               7,218

People & Places Solutions

17,498

  

17,527

Divergent Solutions

2,965

  

3,019

PA Consulting

355

  

326

            Total

$             28,915

  

$             28,090

 

Non-GAAP Financial Measures and Operating Metrics:
In this press release, the Company has included certain non-GAAP financial measures as defined in Regulation G promulgated under the Securities Exchange Act of 1934, as amended. These non-GAAP measures are described below.

Adjusted Net revenue is calculated excluding pass through revenue of the Company's People & Places Solutions and Divergent Solutions segments from the Company's revenue from continuing operations. Pass through revenues are amounts we bill to clients on projects where we are procuring subcontract labor or third-party materials and equipment on behalf of the client. These amounts are considered pass throughs because we receive no or only a minimal mark-up associated with the billed amounts.

Adjusted operating profit, adjusted earnings from continuing operations before taxes, adjusted income taxes from continuing operations, adjusted net earnings from continuing operations and adjusted EPS from continuing operations are calculated by:

1.

Excluding items collectively referred to as Restructuring, Transaction and Other Charges, which include:
 

a.

costs and other charges associated with our Focus 2023 transformation initiatives, including activities associated with the re-scaling and repurposing of physical office space, employee separations, contractual termination fees and related expenses, referred to as "Focus 2023 Transformation, mainly real estate rescaling efforts";
 

b.

transaction costs and other charges incurred in connection with the acquisitions of Buffalo Group, BlackLynx and StreetLight and the strategic investment in PA Consulting, including advisor fees, change in control payments, and the impact of the quarterly adjustment to the estimated performance based payout of contingent consideration to the sellers in connection with certain acquisitions; and similar transaction costs and expenses (collectively referred to as "Transaction Costs");
 

c.

recoveries, costs and other charges associated with restructuring activities implemented in connection with our announced plan to separate the CMS business, including advisor fees and related costs, the acquisitions of CH2M, John Wood Group nuclear business, Buffalo Group, BlackLynx, and StreetLight, the strategic investment in PA Consulting, the sale of the ECR business and other related cost reduction initiatives, which included involuntary terminations, costs associated with co-locating offices of acquired companies, separating physical locations of continuing operations, professional services and personnel costs, amounts relating to certain commitments and contingencies relating to discontinued operations of the CH2M business, including the final settlement charges relating to the Legacy CH2M Matter, net of previously recorded reserves and charges associated with the impairment and final closing activities of our AWE ML joint venture (collectively referred to as "Restructuring, integration, separation and other charges").
   

2.

Excluding items collectively referred to as Other adjustments, which include:
 

a.

adding back amortization of intangible assets;
 

b.

impact of certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment;
 

c.

certain non-routine income tax adjustments for the purposes of calculating the Company's annual non-GAAP effective tax rate to facilitate a more meaningful evaluation of the Company's current operating performance and comparisons to the Company's operating performance in other periods.

Adjustments to derive adjusted net earnings from continuing operations and adjusted EPS from continuing operations are calculated on an after-tax basis.

Adjusted EBITDA is calculated by adding income tax expense, depreciation expense and adjusted interest expense, and deducting interest income from adjusted net earnings from continuing operations.

Certain percentage changes are quantified on a constant currency basis, which provides information assuming that foreign currency exchange rates have not changed between the prior and current periods. For purposes of constant currency calculations, we use the prior period average exchange rates as applied to the current period adjusted amounts.

We believe that the measures listed above are useful to management, investors and other users of our financial information in evaluating the Company's operating results and understanding the Company's operating trends by excluding or adding back the effects of the items described above and below, the inclusion or exclusion of which can obscure underlying trends. Additionally, management uses such measures in its own evaluation of the Company's performance, particularly when comparing performance to past periods, and believes these measures are useful for investors because they facilitate a comparison of our financial results from period to period.

This press release also contains certain operating metrics which management believes are useful in evaluating the Company's performance. Backlog represents revenue or gross margin, as applicable, we expect to realize for work to be completed by our consolidated subsidiaries and our proportionate share of work to be performed by unconsolidated joint ventures. For more information on how we determine our backlog, see our Backlog Information in our most recent quarterly or annual report filed with the Securities and Exchange Commission. We regularly monitor these operating metrics to evaluate our business, identify trends affecting our business, and make strategic decisions.

The Company provides non-GAAP measures to supplement U.S. GAAP measures, as they provide additional insight into the Company's financial results. However, non-GAAP measures have limitations as analytical tools and should not be considered in isolation and are not in accordance with, or a substitute for, U.S. GAAP measures. In addition, other companies may define non-GAAP measures differently, which limits the ability of investors to compare non-GAAP measures of the Company to those used by our peer companies.

The following tables reconcile the components and values of U.S. GAAP earnings from continuing operations before taxes, income taxes from continuing operations, net earnings attributable to Jacobs from continuing operations and Diluted Net Earnings from Continuing Operations Per Share (which we refer to as EPS from continuing operations) to the corresponding "adjusted" amount and revenue to adjusted net revenue. For the comparable periods presented below, such adjustments consist of amounts incurred in connection with the items described above. Amounts are shown in thousands, except for per-share data (note: earnings per share amounts may not add across due to rounding).

Reconciliation of Operating Profit to Adjusted Operating Profit (in thousands)
 
 

Three Months Ended

  

Nine Months Ended
 

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Operating Profit

269,741

  

265,762

  

797,408

  

609,310

Restructuring, Transaction and Other Charges
(1)

              

Focus 2023 Transformation, mainly real estate
rescaling efforts

1,400

  

2,237

  

40,228

  

84,048

Transaction costs

4,062

  

5,443

  

15,613

  

18,204

Restructuring, integration, separation and other
charges

29,783

  

2,470

  

38,900

  

108,734

Other Adjustments (2)

              

Amortization of intangibles

51,985

  

51,551

  

152,232

  

146,889

Other

4,016

  

—

  

5,142

  

—

Adjusted Operating Profit

$        360,987

  

$        327,463

  

$      1,049,523

  

$        967,185
 

(1) Includes estimated operating profit impacts from restructuring charges relating to the Company's investment in PA Consulting and relating to the separation activities around the CMS spin-off for the three- and nine- months ended June 30, 2023, along with real estate impairments associated with the Company's Focus 2023 transformation program for the three- and nine- months ended June 30, 2023 and July 1, 2022 and for the nine months ended July 1, 2022 related to the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves, as well as operating profit impacts from charges associated with various transaction costs incurred with our acquisition and restructuring related activity associated with Company restructuring and integration programs.

(2) Includes estimated operating profit impacts from amortization of intangible assets for the three- and nine- months ended June 30, 2023 and July 1, 2022 and estimated operating profit impacts on certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment for the three- and nine-months ended June 30, 2023.

 

Reconciliation of Earnings from Continuing Operations Before Taxes to Adjusted Earnings from Continuing Operations Before Taxes
(in thousands)
 
 

Three Months Ended

  

Nine Months Ended
 

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Earnings from Continuing Operations Before Taxes

$           226,685

  

$        272,115

  

$          676,478

  

$        596,485

Restructuring, Transaction and Other Charges
(1):

              

Focus 2023 Transformation, mainly real estate
rescaling efforts

1,129

  

2,202

  

39,296

  

76,934

Transaction costs

4,062

  

5,442

  

15,613

  

18,204

Restructuring, integration, separation and other
charges

29,783

  

2,375

  

38,900

  

105,166

Other Adjustments (2):

              

Amortization of intangibles

51,985

  

51,551

  

152,232

  

146,889

Other

4,016

  

—

  

5,142

  

5

Adjusted Earnings from Continuing Operations
Before Taxes

$           317,660

  

$        333,685

  

$          927,661

  

$        943,683
 

(1) Includes pre-tax non-cash charges relating to the Company's investment in PA Consulting and relating to the separation activities around the CMS spin-off for the three- and nine- months ended June 30, 2023, along with real estate impairments charges associated with the Company's Focus 2023 transformation program of $0.9 million and $— million for the three-months ended June 30, 2023 and July 1, 2022, respectively, and $38.1 million and $74.6 million for the nine-months ended June 30, 2023 and July 1, 2022, respectively. The nine months ended July 1, 2022 includes $91.3 million related to the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves. Also includes charges associated with various transaction costs incurred with our acquisition and restructuring related activity associated with Company restructuring and integration programs.

(2) Includes pre-tax charges for the removal of amortization of intangible assets for the three- and nine- months ended June 30, 2023 and July 1, 2022, respectively, and the impact of certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment of $4.0 million and $5.1 million for the three- and nine- months ended June 30, 2023.

 

Reconciliation of Income Tax Expense from Continuing Operations to Adjusted Income Tax Expense from Continuing Operations
(in thousands)
 
 

Three Months Ended

  

Nine Months Ended
 

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Income Tax Expense from Continuing Operations

$       (54,166)

  

$       (59,491)

  

$       (123,329)

  

$       (121,545)

Tax Effects of Restructuring, Transaction and Other Charges (1)

              

Focus 2023 Transformation, mainly real estate rescaling efforts

(286)

  

(549)

  

(9,870)

  

(16,089)

Transaction costs

(173)

  

(1,338)

  

(2,910)

  

(4,476)

Restructuring, integration, separation and other charges

(5,599)

  

(553)

  

(7,795)

  

(18,976)

Tax Effects of Other Adjustments (2)

              

Amortization of intangibles

(12,393)

  

(11,656)

  

(36,304)

  

(32,891)

Other income tax adjustments

6,669

  

1,177

  

(13,594)

  

(10,801)

Other

(761)

  

—

  

(1,009)

  

(1)

Adjusted Income Tax Expense from Continuing Operations

$        (66,709)

  

$       (72,410)

  

$       (194,811)

  

$       (204,779)
 

(1) Includes estimated income tax impacts on restructuring activities around the Company's investment in PA Consulting and relating to the separation activities around the CMS spin-off for the three- and nine- months ended June 30, 2023, along with real estate impairments associated with the Company's Focus 2023 transformation program for the three- and nine- months ended June 30, 2023 and July 1, 2022 and related to the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves for the nine months ended July 1, 2022, as well as tax impacts on charges associated with various transaction costs incurred with our acquisition and restructuring related activity associated with Company restructuring and integration programs.

(2) Includes estimated income tax impacts on amortization of intangible assets for the three- and nine- months ended June 30, 2023 and July 1, 2022, certain income tax adjustments for the purposes of presenting the Company's expected annual non-GAAP effective tax rate to facilitate a more meaningful evaluation of the Company's current operating performance and comparisons to the Company's operating performance in other periods and estimated tax impacts on certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment for the three- and nine-months ended June 30, 2023.

 

Reconciliation of Net Earnings Attributable to Jacobs from Continuing Operations to Adjusted Net Earnings Attributable to Jacobs
from Continuing Operations (in thousands)
 
 

Three Months Ended

  

Nine Months Ended
 

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Net Earnings Attributable to Jacobs from
Continuing Operations

$        163,945

  

$        196,326

  

$        516,886

  

$        419,408

After-tax effects of Restructuring, Transaction
and Other Charges (1):

              

Focus 2023 Transformation, mainly real estate
rescaling efforts

843

  

1,655

  

29,426

  

60,844

Transaction costs

3,155

  

4,105

  

10,947

  

13,728

Restructuring, integration, separation and other
charges

19,571

  

1,657

  

26,492

  

85,767

After-tax effects of Other Adjustments (2):

              

Amortization of intangibles

34,623

  

34,452

  

101,055

  

96,965

Other income tax adjustments

6,955

  

1,627

  

(13,242)

  

(10,612)

Other

2,231

  

—

  

2,772

  

4

Adjusted Net Earnings Attributable to Jacobs
from Continuing Operations

$        231,323

  

$        239,822

  

$        674,336

  

$        666,104
 

(1) Includes estimated after-tax and related noncontrolling interest impacts from restructuring activities around the Company's investment in PA Consulting and relating to the separation activities around the CMS spin-off for the three- and nine- months ended June 30, 2023, along with non-cash real estate impairment charges associated the Company's Focus 2023 program for the three- and nine-months ended June 30, 2023 and July 1, 2022, and for the nine-months ended July 1, 2022, the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves. Also includes charges associated with various transaction costs incurred with our acquisition and restructuring related activity associated with Company restructuring and integration programs.

(2) Includes estimated after-tax and noncontrolling interest impacts from amortization of intangible assets for the three- and nine-months ended June 30, 2023 and July 1, 2022, certain income tax adjustments for the purposes of presenting the Company's expected annual non-GAAP effective tax rate to facilitate a more meaningful evaluation of the Company's current operating performance and comparisons to the Company's operating performance in other periods and estimated tax impacts on certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment for the three- and nine-months ended June 30, 2023.

 

Reconciliation of Diluted Net Earnings from Continuing Operations Per Share to Adjusted Diluted Net Earnings from Continuing
Operations Per Share (in thousands)
 
 

Three Months Ended

  

Nine Months Ended
 

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Diluted Net Earnings from Continuing Operations
Per Share

$               1.29

  

$             1.52

  

$               4.06

  

$              3.23

After-tax effects of Restructuring, Transaction
and Other Charges (1):

              

Focus 2023 Transformation, mainly real estate
rescaling efforts

0.01

  

0.01

  

0.23

  

0.48

Transaction costs

0.02

  

0.03

  

0.09

  

0.11

Restructuring, integration, separation and other
charges

0.15

  

0.02

  

0.21

  

0.65

After-tax effects of Other Adjustments (2):

              

Amortization of intangibles

0.27

  

0.27

  

0.79

  

0.75

Other income tax adjustments

0.05

  

0.01

  

(0.10)

  

(0.08)

Other

0.02

  

—

  

0.02

  

—

Adjusted Diluted Net Earnings from Continuing
Operations Per Share

$               1.82

  

$             1.86

  

$               5.30

  

$             5.13
 

(1) Includes estimated per-share impacts from the restructuring activities around the Company's investment in PA Consulting and relating to the separation activities around the CMS spin-off for the three- and nine- months ended June 30, 2023, along with real estate impairments associated with the Company's Focus 2023 transformation program for the three- and nine-months ended June 30, 2023 and July 1, 2022, and for the nine-months ended July 1, 2022, the final pre-tax settlement of the Legacy CH2M Matter, net of previously recorded reserves. Also includes related impacts associated with various transaction costs incurred with our acquisition and restructuring related activity costs associated with Company restructuring and integration programs.

(2) Includes estimated per-share impacts from amortization of intangible assets for the three- and nine-months ended June 30, 2023 and July 1, 2022, certain income tax adjustments for the purposes of presenting the Company's expected annual non-GAAP effective tax rate to facilitate a more meaningful evaluation of the Company's current operating performance and comparisons to the Company's operating performance in other periods and certain subsidiary level contingent equity-based agreements in connection with the transaction structure of our PA Consulting investment for the three- and nine-months ended June 30, 2023.

 

Reconciliation from Revenue to constant currency Revenue
 
 

Three Months Ended

(in millions)

June 30, 2023

  

July 1, 2022

  

% Change
           

Revenue

$          4,187

  

$          3,827

  

9.4 %

Exchange rate effect

$               12

        

Constant currency Revenue

$          4,199

      

9.7 %
 
 

Reconciliation from Adjusted Net Revenue to constant currency Adjusted Net Revenue
 
 

Three Months Ended

(in millions)

June 30, 2023

  

July 1, 2022

  

% Change
           

Adjusted Net Revenue

$          3,383

  

$          3,147

  

7.5 %

Exchange rate effect

$               13

        

Constant currency Adjusted Net Revenue

$          3,396

      

7.9 %

 

Earnings Per Share:
 
 

Three Months Ended

  

Nine Months Ended

Unaudited

June 30, 2023

  

July 1, 2022

  

June 30, 2023

  

July 1, 2022

Numerator for Basic and Diluted EPS:

              

Net earnings attributable to Jacobs from continuing operations

$      163,945

  

$   196,326

  

$      516,886

  

$   419,408

Net earnings from continuing operations allocated to common
stock for EPS calculation

$      163,945

  

$   196,326

  

$      516,886

  

$   419,408
               

Net earnings (loss) from discontinued operations allocated to
common stock for EPS calculation

$             294

  

$         (343)

  

$            (489)

  

$         (576)
               

Net earnings allocated to common stock for EPS calculation

$      164,239

  

$   195,983

  

$      516,397

  

$   418,832
               

Denominator for Basic and Diluted EPS:

              
               

Shares used for calculating basic EPS attributable to common
stock

126,646

  

128,225

  

126,785

  

128,966
               

Effect of dilutive securities:

              

Stock compensation plans

492

  

708

  

546

  

767

Shares used for calculating diluted EPS attributable to common
stock

127,138

  

128,933

  

127,331

  

129,733
               

Net Earnings Per Share:

              

Basic Net Earnings from Continuing Operations Per Share

$            1.29

  

$         1.53

  

$            4.08

  

$         3.25

Basic Net Loss from Discontinued Operations Per Share

$               —

  

$            —

  

$               —

  

$            —

Basic Earnings Per Share

$            1.30

  

$         1.53

  

$            4.07

  

$         3.25

Diluted Net Earnings from Continuing Operations Per Share

$            1.29

  

$         1.52

  

$            4.06

  

$         3.23

Diluted Net Loss from Discontinued Operations Per Share

$               —

  

$            —

  

$               —

  

$            —

Diluted Earnings Per Share

$            1.29

  

$         1.52

  

$            4.06

  

$         3.23
 

Note: Per share amounts may not add due to rounding.

For additional information contact:

Investors:
Jonathan Evans
investor.relations@jacobs.com 

Media:
Louise White
louise.white@jacobs.com 

 

 

View original content to download multimedia: https://www.prnewswire.com/news-releases/jacobs-reports-fiscal-third-quarter-2023-earnings-301895230.html

SOURCE Jacobs